Presentation is loading. Please wait.

Presentation is loading. Please wait.

(6h ) Supplemental Fig. 2 a. 32Dp210 b. 32Dp210 c. 32DP210

Published byBethany Oliver Modified over 6 years ago

Similar presentations

Presentation on theme: "(6h ) Supplemental Fig. 2 a. 32Dp210 b. 32Dp210 c. 32DP210"— Presentation transcript:

1 (6h ) Supplemental Fig. 2 a. 32Dp210 b. 32Dp210 c. 32DP210
C (min) pTyr 360 Bcr-Abl Grb2 WP1193 (M) WB a Dp210 WP1193 (M) Untreated Image Quant (%) Jak2 IP: Jak2 32P pJak2 (WB) b Dp210 C (min) pTyr177 Bcr-Abl pGab2 Gab2 GRB2 WP1193 (10M) (WB) c. 32DP210 C (min) pTyr177 Bcr-Abl Bcr-Abl  - Actin WP1193 (10M) (WB) d K562-R C (min) pSTAT5 (Tyr694)  - Actin (WB) WP1193 (10 M) e DP210 pBcr-Abl  - Actin anti-Abl WP1193 (M) Untreated (WB) Anti-pTyr Ab4G10 f Dp210 Imatinib (M) C P32 pBcr-Abl Bcr-Abl kinase  - Actin (Sup) anti- Abl g Dp210 pTyr177 Bcr-Abl Bcr-Abl b-Actin WP1193 (mM) C (6h ) WB h.

Download ppt "(6h ) Supplemental Fig. 2 a. 32Dp210 b. 32Dp210 c. 32DP210"

Similar presentations

National Cancer Institute Milan, Italy University of Milano Bicocca, Monza, Italy Molecular Mechanisms of Resistance to Imatinib (STI571, CGP57148B)

National Cancer Institute Milan, Italy University of Milano Bicocca, Monza, Italy Molecular Mechanisms of Resistance to Imatinib (STI571, CGP57148B)
Fig. 4-1, p. 107. Fig. 4-2, p. 109 Fig. 4-3, p. 110.

Fig. 4-1, p Fig. 4-2, p. 109 Fig. 4-3, p. 110.
Suppl. Fig.1 46 58 80 30 - + + TET -  -Flag  -Tub Flag-TDP-43WT Flag-TDP-12xQ/N.

Suppl. Fig TET -  -Flag  -Tub Flag-TDP-43WT Flag-TDP-12xQ/N.
Management of Side Effects Monica Davey, RN BSN MEd MBA Clinical Research Nurse Coordinator Sarcoma Program Fox Chase Cancer Center Philadelphia, PA.

Management of Side Effects Monica Davey, RN BSN MEd MBA Clinical Research Nurse Coordinator Sarcoma Program Fox Chase Cancer Center Philadelphia, PA.
Apaf-1 Caspase-9 Cyt c control sulindac control E LY294002 control TRAIL thapsigargin HT-29Chondrocyte control SIN-1 RAW 264.7 IP: AChE C Supplementary.

Apaf-1 Caspase-9 Cyt c control sulindac control E LY control TRAIL thapsigargin HT-29Chondrocyte control SIN-1 RAW IP: AChE C Supplementary.
The key to success in GCSE maths. Examiners estimate that candidates who show working out get 10% more marks than those who don’t.

The key to success in GCSE maths. Examiners estimate that candidates who show working out get 10% more marks than those who don’t.
P.464. Table 13-1, p.465 Fig. 13-1, p.466 Fig. 13-2, p.467.

P.464. Table 13-1, p.465 Fig. 13-1, p.466 Fig. 13-2, p.467.
Fig. 11-1, p. 359. p. 360 Fig. 11-2, p. 361 Fig. 11-3, p. 361.

Fig. 11-1, p p. 360 Fig. 11-2, p. 361 Fig. 11-3, p. 361.
Table 6-1, p. 161. Fig. 6-1, p. 162 p. 163 Fig. 6-2, p. 164.

Table 6-1, p Fig. 6-1, p. 162 p. 163 Fig. 6-2, p. 164.
Figure 1.1 The observer in the truck sees the ball move in a vertical path when thrown upward. (b) The Earth observer views the path of the ball as a parabola.

Figure 1.1 The observer in the truck sees the ball move in a vertical path when thrown upward. (b) The Earth observer views the path of the ball as a parabola.
Supplementary Figure S1

Supplementary Figure S1
Targeting Drug-Insensitive CML Stem/Progenitor Cells with Combination Treatments of New ABL and PP2A Inhibitors Damian Lai SRD 2014.

Targeting Drug-Insensitive CML Stem/Progenitor Cells with Combination Treatments of New ABL and PP2A Inhibitors Damian Lai SRD 2014.
Figure 1 A -SN50-C8-S-A2-G7 B C HCT116-sHCT116-SN6 NTSN38NTSN38 HCT116-s pp38 tubulin NT 0.1µM 1µM 5µM 10µM pp38 tubulin HCT116-SN6 [SN38] 24H pp38 NT.

Figure 1 A -SN50-C8-S-A2-G7 B C HCT116-sHCT116-SN6 NTSN38NTSN38 HCT116-s pp38 tubulin NT 0.1µM 1µM 5µM 10µM pp38 tubulin HCT116-SN6 [SN38] 24H pp38 NT.
AntibodyCatalog #Company Desminab15200Abcam Smooth muscle actinab5694Abcam S100ab868Abcam Cytokeration(AE1/AE3)ab961Abcam P53sc-6243Santa Cruz Calponinab46794Abcam.

AntibodyCatalog #Company Desminab15200Abcam Smooth muscle actinab5694Abcam S100ab868Abcam Cytokeration(AE1/AE3)ab961Abcam P53sc-6243Santa Cruz Calponinab46794Abcam.
Supplemental Figure S1 ResidueMass Delta Mass Sequence Mascot Ion Score 62 - 701064.640.04R.DFGLLVFVR.K49 125 - 133994.680.04K.IPALDLLIK.L56 156 - 163939.550.04K.FYGELALK.K34.

Supplemental Figure S1 ResidueMass Delta Mass Sequence Mascot Ion Score R.DFGLLVFVR.K K.IPALDLLIK.L K.FYGELALK.K34.
Supplemental Fig. 1 100  m B 50  m A. IL-1  secretion (pg/well) Y27632 Z-YVAD Asbestos Control Y27632 Z-YVAD CNT Control Y27632 Z-YVAD LPS Control.

Supplemental Fig  m B 50  m A. IL-1  secretion (pg/well) Y27632 Z-YVAD Asbestos Control Y27632 Z-YVAD CNT Control Y27632 Z-YVAD LPS Control.
A B A Stat3:Stat3 Supershift  -ST3 Free probe BP1-102 (µM) 0 5 10 20 Stat3:Stat3 % of Cont 100 56 43 1 Supplementary Figures Fig. S1 -

A B A Stat3:Stat3 Supershift  -ST3 Free probe BP1-102 (µM) Stat3:Stat3 % of Cont Supplementary Figures Fig. S1 -
如何利用图书馆 ——— 海南师范大学图书馆（ 2014 ） ——— 海南师范大学图书馆（ 2014 ）

如何利用图书馆 ——— 海南师范大学图书馆（ 2014 ） ——— 海南师范大学图书馆（ 2014 ）
Image from

Image from
The reading is 7.38 mm. The reading is 7.72 mm.

The reading is 7.38 mm. The reading is 7.72 mm.

Similar presentations

Ads by Google